The South Carolina Supreme Court considered arguments Wednesday in the appeal of convicted murderer Alex Murdaugh, who seeks a new trial in the 2021 killings of his wife and son. NewsNation’s Laura Ingle has the latest details. #Crime #AlexMurdaugh #Appeal Get a fast-paced look at the latest from the border to Main Street to the White House on "NewsNation Live" with Connell McShane. Weekdays starting at 3p/2C. NewsNation is your source for fact-based, unbiased news for all Americans.
Rep. Kevin Kiley, R-Calif., joins “The Hill” to discuss U.S. Attorney General Pam Bondi’s heated hearing with several lawmakers over the DOJ’s handling of the Jeffrey Epstein files. #pambondi #doj #jeffreyepstein "The Hill on NewsNation" combines the power of two trusted news sources to define today's most-pressing issues, and question Washington's power brokers on what matters most to the people they serve and what matters most to Americans.
Two former Jacksonville teachers union leaders were sentenced to prison after pleading guilty to a $2.6 million fraud scheme. But this isn’t an isolated case. From union theft to districtwide embezzlement, education corruption has surfaced across the country. Do you think more federal oversight is needed or local accountability? Let me know in the comments. Please head to the website to purchase some merch www.nelliemiranda.com
Like it or not, the justices are about to see AI versions of themselves, speaking words that they spoke in court but that were not heard contemporaneously by anyone except those in the courtroom.
PULSE POINTSWHAT HAPPENED: Some pharmaceutical companies not directly contacted by the Trump administration to lower U.S. drug prices are seeking to craft their own agreements to avoid potential tariffs and price-setting programs.WHO WAS INVOLVED: The Trump administration, pharmaceutical companies including Bayer, Pfizer, Eli Lilly, and industry groups such as PhRMA and the Midsized Biotech Alliance […] The post More Pharma Firms Want to Make Drug Price Deals With Trump. appeared first on The National Pulse .
PULSE POINTS WHAT HAPPENED: Some pharmaceutical companies not directly contacted by the Trump administration to lower U.S. drug prices are seeking to craft their own agreements to avoid potential tariffs and price-setting programs. WHO WAS INVOLVED: The Trump administration, pharmaceutical companies including Bayer, Pfizer, Eli Lilly, and industry groups such as PhRMA and the Midsized Biotech Alliance of America. WHEN & WHERE: Ongoing discussions following directives issued by the Trump administration in the U.S.; recent comments made at the JP Morgan Healthcare Conference in San Francisco. KEY QUOTE: “The Trump administration, of course, wants to negotiate deals that meaningfully lower drug prices for American patients with every…Open
